Cargando…
The SV40 replicon model for analysis of anticancer drugs /
This book provides the most up-to-date review of the simian virus 40 (SV40) minichromosome as a model for the mammalian chromosome in studies of DNA replication. It focuses on disruption of DNA replication by anticancer drugs and DNA-damaging agents. There is a strong emphasis on the unique advantag...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
[San Diego, Calif.] : Austin, TX :
Academic Press ; R.G. Landes,
©1996.
|
| Colección: | Molecular biology intelligence unit (Unnumbered)
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn743111491 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr un||||a|a|| | ||
| 008 | 110724s1996 caua ob 001 0 eng d | ||
| 010 | |z 96000579 | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d N$T |d YDXCP |d IDEBK |d OCLCQ |d MERUC |d OCLCQ |d NLGGC |d OCLCQ |d TOA |d AGLDB |d OCLCO |d OCLCQ |d OCLCA |d OCLCF |d VNS |d OCLCO |d OCLCQ |d VTS |d OCLCO |d OCLCA |d REC |d STF |d M8D |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d INARC |d OCLCO |d OCLCA |d OCLCQ |d OCLCO | ||
| 019 | |a 173519148 |a 823827466 |a 823897246 |a 824089006 |a 824135404 |a 1302554474 | ||
| 020 | |a 9780080550183 |q (electronic bk.) | ||
| 020 | |a 0080550185 |q (electronic bk.) | ||
| 020 | |a 1281018910 | ||
| 020 | |a 9781281018915 | ||
| 020 | |z 0126536309 | ||
| 020 | |z 9780126536300 | ||
| 020 | |z 0412105217 |q (alk. paper) | ||
| 020 | |z 9780412105210 |q (alk. paper) | ||
| 029 | 1 | |a DEBBG |b BV043131699 | |
| 029 | 1 | |a DEBSZ |b 422184942 | |
| 029 | 1 | |a GBVCP |b 803613369 | |
| 035 | |a (OCoLC)743111491 |z (OCoLC)173519148 |z (OCoLC)823827466 |z (OCoLC)823897246 |z (OCoLC)824089006 |z (OCoLC)824135404 |z (OCoLC)1302554474 | ||
| 050 | 4 | |a QR406.2.S56 |b S64 1996 | |
| 060 | 4 | |a 1997 L-118 | |
| 060 | 4 | |a QW 165.5.P2 |b S669s 1996 | |
| 070 | |a QR406.2.S56S64 |b 1996 | ||
| 072 | 0 | |a X300 | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a MBGR |2 bicssc | |
| 082 | 0 | 4 | |a 616.99/4061 |2 20 |
| 084 | |a VS 9100 |2 rvk | ||
| 084 | |a XI 7000 |2 rvk | ||
| 049 | |a UAMI | ||
| 100 | 1 | |a Snapka, Robert M., |d 1947- | |
| 245 | 1 | 4 | |a The SV40 replicon model for analysis of anticancer drugs / |c Robert M. Snapka. |
| 260 | |a [San Diego, Calif.] : |b Academic Press ; |a Austin, TX : |b R.G. Landes, |c ©1996. | ||
| 300 | |a 1 online resource (193 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Molecular biology intelligence unit | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Front Cover; The SV40 Replicon Model for Analysis of Anticancer Drugs; Copyright Page; Contents; Chapter 1. Papovavirus Models for Mammalian Replicons; Chapter 2. Analysis of SV40 DNA Replication Intermediates; Chapter 3. Catastrophic Failure of DNA Replication Forks: Structural and Recombinational Pathways; Chapter 4. Topoisomerase II and Termination of DNA Replication; Chapter 5. DNA Damaging Agents; Chapter 6. Drug Discovery and Evaluation with SV40; Chapter 7. SV40 In Vitro DNA Replication: A Potential Model For Studying Anticancer Drug Action. | |
| 520 | |a This book provides the most up-to-date review of the simian virus 40 (SV40) minichromosome as a model for the mammalian chromosome in studies of DNA replication. It focuses on disruption of DNA replication by anticancer drugs and DNA-damaging agents. There is a strong emphasis on the unique advantages of SV40 as an experimental system for the analysis of these classes of anticancer drug mechanisms. The new high-resolution gel electrophoresis methods for the analysis of SV40 DNA replication are covered in detail to aid readers in designing and interpreting similar experiments. | ||
| 588 | 0 | |a Print version record. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a SV40 (Virus) | |
| 650 | 0 | |a Viral genetics. | |
| 650 | 0 | |a Antineoplastic agents |x Research |x Methodology. | |
| 650 | 0 | |a DNA-drug interactions. | |
| 650 | 1 | 2 | |a Simian virus 40 |x drug effects |
| 650 | 1 | 2 | |a Simian virus 40 |x genetics |
| 650 | 2 | 2 | |a DNA Replication |x drug effects |
| 650 | 2 | 2 | |a Models, Genetic |
| 650 | 2 | |a Simian virus 40 | |
| 650 | 6 | |a Virus SV 40. | |
| 650 | 6 | |a Génétique virale. | |
| 650 | 6 | |a Anticancéreux |x Recherche |x Méthodologie. | |
| 650 | 6 | |a Interactions ADN-médicament. | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a DNA-drug interactions |2 fast | |
| 650 | 7 | |a SV40 (Virus) |2 fast | |
| 650 | 7 | |a Viral genetics |2 fast | |
| 650 | 7 | |a Arzneimittelentwicklung |2 gnd | |
| 650 | 7 | |a Arzneimittelwechselwirkung |2 gnd | |
| 650 | 7 | |a Cytostatikum |2 gnd | |
| 650 | 7 | |a Simian Sarkomvirus |2 gnd | |
| 650 | 7 | |a DNS |2 gnd | |
| 655 | 7 | |a Repliken. |2 swd | |
| 776 | 0 | 8 | |i Print version: |a Snapka, Robert M., 1947- |t SV40 replicon model for analysis of anticancer drugs. |d [San Diego, Calif.] : Academic Press ; Austin, TX : R.G. Landes, ©1996 |w (DLC) 96000579 |w (OCoLC)34121051 |
| 830 | 0 | |a Molecular biology intelligence unit (Unnumbered) | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=203138 |z Texto completo |
| 938 | |a EBSCOhost |b EBSC |n 203138 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 101891 | ||
| 938 | |a YBP Library Services |b YANK |n 2711981 | ||
| 938 | |a Internet Archive |b INAR |n sv40repliconmode0000snap | ||
| 994 | |a 92 |b IZTAP | ||